Compare Mitra Investindo Tbk. (MITI) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mitra Investindo Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Mitra Investindo Tbk. trades at Rp191 (market cap 723.85B, 1.58M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 229.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 17.4× Mitra Investindo Tbk.'s market cap, and Mitra Investindo Tbk. is more actively traded (1.58M versus 229.7K). Which is the better fit depends on your goals.
| MITI | TSPC | |
|---|---|---|
Market Cap | 723.85B | 12.58T |
Volume | 1.58M | 229.7K |
Lot | 15.82K | 2.3K |
Turnover | 299.25M | 634.65M |
Average Price | 189.21 | 2,762.97 |
Value | 299.25M | 634.65M |
Indicative Equilibrium Price | 191 | 2,780 |
Indicative Equilibrium Volume | 398 | 9 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mitra Investindo Tbk.
PT Mitra Investindo Tbk (the Company) was established based on notarial deed No. 280 dated 16 September 1993 of Misahardi Wilamarta, S.H., notary in Jakarta, under the name of PT Minsuco International Finance. The Company's Articles of Association was amended several times, which one of the amendments was based on notarial deed No. 10 dated 15 March 2006 of Amrul Partomuan Pohan, S.H., llm., Notary in Jakarta, concerning the merger of PT Siwani Trinitra Tbk with PT Caraka Berkat Sarana to become PT Mitra Investindo Tbk.
Read more on MITI →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
